Zhejiang Hisun Pharmaceutical Co Ltd (600267) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥438.43 Million ≈ $64.16 Million USD) by net assets (CN¥8.76 Billion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Hisun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)
This chart illustrates how Zhejiang Hisun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Zhejiang Hisun Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
Zhejiang Hisun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Hisun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Veeco Instruments Inc
NASDAQ:VECO
|
0.018x |
|
Shenzhen Rongda Photosensitive & Technology Co Ltd
SHE:300576
|
0.035x |
|
Westone Information Industry Inc
SHE:002268
|
-0.034x |
|
Schiehallion Fund Ltd
LSE:MNTN
|
-0.004x |
|
AMP Limited
F:AMP
|
-0.012x |
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
0.077x |
|
Ocular Therapeutix Inc
NASDAQ:OCUL
|
-0.083x |
|
Triumph Group Inc
NYSE:TGI
|
-1.931x |
Annual Cash Flow Conversion Efficiency for Zhejiang Hisun Pharmaceutical Co Ltd (1999–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Hisun Pharmaceutical Co Ltd from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see 600267 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥8.58 Billion ≈ $1.26 Billion |
CN¥2.11 Billion ≈ $309.42 Million |
0.246x | +35.66% |
| 2023-12-31 | CN¥8.35 Billion ≈ $1.22 Billion |
CN¥1.52 Billion ≈ $221.98 Million |
0.182x | -26.73% |
| 2022-12-31 | CN¥8.33 Billion ≈ $1.22 Billion |
CN¥2.07 Billion ≈ $302.28 Million |
0.248x | +4.90% |
| 2021-12-31 | CN¥7.35 Billion ≈ $1.07 Billion |
CN¥1.74 Billion ≈ $254.11 Million |
0.236x | +22.79% |
| 2020-12-31 | CN¥8.26 Billion ≈ $1.21 Billion |
CN¥1.59 Billion ≈ $232.61 Million |
0.193x | +111.79% |
| 2019-12-31 | CN¥7.68 Billion ≈ $1.12 Billion |
CN¥698.39 Million ≈ $102.20 Million |
0.091x | -53.62% |
| 2018-12-31 | CN¥7.38 Billion ≈ $1.08 Billion |
CN¥1.45 Billion ≈ $211.64 Million |
0.196x | +24.42% |
| 2017-12-31 | CN¥7.88 Billion ≈ $1.15 Billion |
CN¥1.24 Billion ≈ $181.55 Million |
0.158x | +63.23% |
| 2016-12-31 | CN¥8.04 Billion ≈ $1.18 Billion |
CN¥775.90 Million ≈ $113.54 Million |
0.097x | +7.05% |
| 2015-12-31 | CN¥8.17 Billion ≈ $1.19 Billion |
CN¥736.17 Million ≈ $107.72 Million |
0.090x | +30.49% |
| 2014-12-31 | CN¥8.26 Billion ≈ $1.21 Billion |
CN¥571.04 Million ≈ $83.56 Million |
0.069x | -21.92% |
| 2013-12-31 | CN¥5.96 Billion ≈ $871.87 Million |
CN¥527.25 Million ≈ $77.15 Million |
0.088x | +22.41% |
| 2012-12-31 | CN¥5.20 Billion ≈ $760.59 Million |
CN¥375.75 Million ≈ $54.98 Million |
0.072x | -36.79% |
| 2011-12-31 | CN¥4.59 Billion ≈ $672.18 Million |
CN¥525.31 Million ≈ $76.87 Million |
0.114x | -38.37% |
| 2010-12-31 | CN¥2.74 Billion ≈ $401.57 Million |
CN¥509.18 Million ≈ $74.51 Million |
0.186x | -4.62% |
| 2009-12-31 | CN¥2.43 Billion ≈ $355.67 Million |
CN¥472.85 Million ≈ $69.19 Million |
0.195x | +36.20% |
| 2008-12-31 | CN¥1.55 Billion ≈ $226.70 Million |
CN¥221.28 Million ≈ $32.38 Million |
0.143x | -55.07% |
| 2007-12-31 | CN¥1.38 Billion ≈ $201.50 Million |
CN¥437.72 Million ≈ $64.05 Million |
0.318x | +273.86% |
| 2006-12-31 | CN¥1.27 Billion ≈ $185.92 Million |
CN¥108.03 Million ≈ $15.81 Million |
0.085x | -8.03% |
| 2005-12-31 | CN¥1.23 Billion ≈ $179.69 Million |
CN¥113.53 Million ≈ $16.61 Million |
0.092x | -64.49% |
| 2004-12-31 | CN¥1.20 Billion ≈ $175.90 Million |
CN¥312.93 Million ≈ $45.79 Million |
0.260x | -9.59% |
| 2003-12-31 | CN¥1.00 Billion ≈ $146.59 Million |
CN¥288.45 Million ≈ $42.21 Million |
0.288x | +96.58% |
| 2002-12-31 | CN¥824.83 Million ≈ $120.70 Million |
CN¥120.82 Million ≈ $17.68 Million |
0.146x | +66.14% |
| 2001-12-31 | CN¥784.18 Million ≈ $114.75 Million |
CN¥69.14 Million ≈ $10.12 Million |
0.088x | +19.97% |
| 2000-12-31 | CN¥757.90 Million ≈ $110.90 Million |
CN¥55.70 Million ≈ $8.15 Million |
0.073x | -43.75% |
| 1999-12-31 | CN¥249.88 Million ≈ $36.56 Million |
CN¥32.64 Million ≈ $4.78 Million |
0.131x | -- |
About Zhejiang Hisun Pharmaceutical Co Ltd
Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss… Read more